Title : Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.

Pub. Date : 2011 Aug

PMID : 21270118






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 DESIGN: Retrospective analysis of HCC incidence in HBeAg-negative chronic hepatitis B patients from a retrospective-prospective cohort who were treated with nucleos(t)ide analogue(s) starting with lamivudine monotherapy for >=12 months. Lamivudine HCC Homo sapiens